{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T21:59:37Z","timestamp":1785275977772,"version":"3.55.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Shandong Province Natural Science Foundation","doi-asserted-by":"publisher","award":["ZR2022MH119"],"award-info":[{"award-number":["ZR2022MH119"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.canlet.2025.218072","type":"journal-article","created":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T19:09:10Z","timestamp":1759518550000},"page":"218072","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Targeting the FBXO5-DOK6 axis to overcome temozolomide resistance in glioblastoma via proteasome-cytomechanics regulation"],"prefix":"10.1016","volume":"634","author":[{"given":"Chao","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenye","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huang","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danchen","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mu","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7301-1479","authenticated-orcid":false,"given":"Mingru","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengyuan","family":"Che","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2025.218072_bib1","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1016\/j.cell.2022.06.054","article-title":"Glioblastoma hijacks neuronal mechanisms for brain invasion","volume":"185","author":"Venkataramani","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2025.218072_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217269","article-title":"Histone acetyltransferases as promising therapeutic targets in glioblastoma resistance","volume":"604","author":"Pathikonda","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2025.218072_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/life14060673","article-title":"Overcoming resistance to temozolomide in glioblastoma: a scoping review of preclinical and clinical data","volume":"14","author":"Smerdi","year":"2024","journal-title":"Life"},{"key":"10.1016\/j.canlet.2025.218072_bib4","doi-asserted-by":"crossref","DOI":"10.1038\/s41417-024-00797-1","article-title":"Deciphering the role of post-translational modifications in Fanconi anemia proteins and their influence on tumorigenesis","author":"Ma","year":"2024","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.canlet.2025.218072_bib5","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1038\/nm.3739","article-title":"Ubiquitination in disease pathogenesis and treatment","volume":"20","author":"Popovic","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2025.218072_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216978","article-title":"Targeting the ubiquitin pathway in lymphoid malignancies","volume":"594","author":"Li","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2025.218072_bib7","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1204","article-title":"The roles of E3 ubiquitin ligases in cancer progression and targeted therapy","volume":"13","author":"Sampson","year":"2023","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.canlet.2025.218072_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102451","article-title":"TRIM7 modulates NCOA4-mediated ferritinophagy and ferroptosis in glioblastoma cells","volume":"56","author":"Li","year":"2022","journal-title":"Redox Biol."},{"key":"10.1016\/j.canlet.2025.218072_bib9","doi-asserted-by":"crossref","first-page":"6321","DOI":"10.1038\/s41467-021-26653-6","article-title":"Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma","volume":"12","author":"Mahlokozera","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2025.218072_bib10","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/s41418-020-00606-w","article-title":"TRIM22 activates NF-kappaB signaling in glioblastoma by accelerating the degradation of IkappaBalpha","volume":"28","author":"Ji","year":"2021","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.canlet.2025.218072_bib11","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1038\/s41388-023-02717-3","article-title":"TRIM25 promotes temozolomide resistance in glioma by regulating oxidative stress and ferroptotic cell death via the ubiquitination of keap1","volume":"42","author":"Wei","year":"2023","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2025.218072_bib12","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1158\/0008-5472.CAN-21-3882","article-title":"TRAF4 maintains deubiquitination of Caveolin-1 to drive glioblastoma stemness and temozolomide resistance","volume":"82","author":"Li","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2025.218072_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216849","article-title":"Cross-talk between BCKDK-mediated phosphorylation and STUB1-dependent ubiquitination degradation of BCAT1 promotes GBM progression","volume":"591","author":"Wang","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2025.218072_bib14","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/nrm3582","article-title":"Mechanisms and function of substrate recruitment by F-box proteins","volume":"14","author":"Skaar","year":"2013","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.canlet.2025.218072_bib15","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1016\/j.cell.2023.02.035","article-title":"Systemwide disassembly and assembly of SCF ubiquitin ligase complexes","volume":"186","author":"Baek","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2025.218072_bib16","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s41586-018-0199-7","article-title":"EMI1 switches from being a substrate to an inhibitor of APC\/C(CDH1) to start the cell cycle","volume":"558","author":"Cappell","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2025.218072_bib17","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s41392-021-00510-w","article-title":"PUMA facilitates EMI1-promoted cytoplasmic Rad51 ubiquitination and inhibits DNA repair in stem and progenitor cells","volume":"6","author":"Kang","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.canlet.2025.218072_bib18","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.2353\/ajpath.2007.060767","article-title":"Oncogenic regulators and substrates of the anaphase promoting complex\/cyclosome are frequently overexpressed in malignant tumors","volume":"170","author":"Lehman","year":"2007","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.canlet.2025.218072_bib19","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s12935-021-01833-y","article-title":"Systematic analysis of the expression and prognosis relevance of FBXO family reveals the significance of FBXO1 in human breast cancer","volume":"21","author":"Liu","year":"2021","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.canlet.2025.218072_bib20","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.molcel.2018.11.003","article-title":"The F-Box domain-dependent activity of EMI1 regulates PARPi sensitivity in triple-negative breast cancers","volume":"73","author":"Marzio","year":"2019","journal-title":"Mol. Cell"},{"key":"10.1016\/j.canlet.2025.218072_bib21","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41392-024-01742-2","article-title":"Docking protein 6 (DOK6) selectively docks the neurotrophic signaling transduction to restrain peripheral neuropathy","volume":"9","author":"Guo","year":"2024","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.canlet.2025.218072_bib22","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/s41580-023-00583-1","article-title":"Cell-extracellular matrix mechanotransduction in 3D","volume":"24","author":"Saraswathibhatla","year":"2023","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.canlet.2025.218072_bib23","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/s41580-022-00500-y","article-title":"Signalling mechanisms and cellular functions of SUMO","volume":"23","author":"Vertegaal","year":"2022","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.canlet.2025.218072_bib24","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41584-022-00778-4","article-title":"Disorders of ubiquitylation: unchained inflammation","volume":"18","author":"Beck","year":"2022","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.canlet.2025.218072_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216875","article-title":"E2F1-regulated USP5 contributes to the tumorigenic capacity of glioma stem cells through the maintenance of OCT4 stability","volume":"593","author":"Jiang","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2025.218072_bib26","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41419-024-06421-2","article-title":"FBXO5-mediated RNF183 degradation prevents endoplasmic reticulum stress-induced apoptosis and promotes colon cancer progression","volume":"15","author":"Ji","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2025.218072_bib27","doi-asserted-by":"crossref","first-page":"5446","DOI":"10.1038\/onc.2016.94","article-title":"In vivo overexpression of Emi1 promotes chromosome instability and tumorigenesis","volume":"35","author":"Vaidyanathan","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2025.218072_bib28","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/neup.12845","article-title":"Identification and characterization of sex-dependent gene expression profile in glioblastoma","volume":"43","author":"Qin","year":"2023","journal-title":"Neuropathology"},{"key":"10.1016\/j.canlet.2025.218072_bib29","doi-asserted-by":"crossref","first-page":"rbac100","DOI":"10.1093\/rb\/rbac100","article-title":"Paxillin tunes the relationship between cell-matrix and cell-cell adhesions to regulate stiffness-dependent dentinogenesis","volume":"10","author":"Bai","year":"2023","journal-title":"Regen. Biomater."},{"key":"10.1016\/j.canlet.2025.218072_bib30","doi-asserted-by":"crossref","first-page":"8846","DOI":"10.1016\/j.biomaterials.2014.07.003","article-title":"A composite hydrogel platform for the dissection of tumor cell migration at tissue interfaces","volume":"35","author":"Rape","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.canlet.2025.218072_bib31","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.201800295","article-title":"Fabrication and characterization of chitosan-hyaluronic acid scaffolds with varying stiffness for glioblastoma cell culture","volume":"7","author":"Erickson","year":"2018","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.canlet.2025.218072_bib32","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.matbio.2022.12.002","article-title":"Substrate stiffness regulates the recurrent glioblastoma cell morphology and aggressiveness","volume":"115","author":"Acharekar","year":"2023","journal-title":"Matrix Biol."},{"key":"10.1016\/j.canlet.2025.218072_bib33","doi-asserted-by":"crossref","DOI":"10.1021\/acsbiomaterials.4c00445","article-title":"Exploiting matrix stiffness to overcome drug resistance","author":"Aydin","year":"2024","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.canlet.2025.218072_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jff.2018.09.021","article-title":"Theaflavin-3, 3'-digallate inhibits ovarian cancer stem cells via suppressing Wnt\/beta-Catenin signaling pathway","volume":"50","author":"Pan","year":"2018","journal-title":"J. Funct.Foods"},{"key":"10.1016\/j.canlet.2025.218072_bib35","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.actbio.2016.11.022","article-title":"Theaflavin-3,3'-digallate represses osteoclastogenesis and prevents wear debris-induced osteolysis via suppression of ERK pathway","volume":"48","author":"Hu","year":"2017","journal-title":"Acta Biomater."},{"key":"10.1016\/j.canlet.2025.218072_bib36","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1038\/s41467-021-23053-8","article-title":"Hyperactivation of HER2-SHCBP1-PLK1 axis promotes tumor cell mitosis and impairs trastuzumab sensitivity to gastric cancer","volume":"12","author":"Shi","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2025.218072_bib37","doi-asserted-by":"crossref","first-page":"803","DOI":"10.3389\/fphar.2020.00803","article-title":"Theaflavin-3, 3'-Digallate suppresses RANKL-Induced osteoclastogenesis and attenuates ovariectomy-induced bone loss in mice","volume":"11","author":"Ai","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.canlet.2025.218072_bib38","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/8966368","article-title":"Theaflavin-3,3'-Digallate plays a ROS-mediated dual role in ferroptosis and apoptosis via the MAPK pathway in human osteosarcoma cell lines and xenografts","volume":"2022","author":"He","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.canlet.2025.218072_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.157014","article-title":"Theaflavin-3,3'-digallate stabilizes vulnerable plaques by reprogramming metabolic homeostasis in neovascularization via HK2\/TIGAR","volume":"145","author":"Cen","year":"2025","journal-title":"Phytomedicine"},{"key":"10.1016\/j.canlet.2025.218072_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.physbeh.2023.114077","article-title":"Theaflavin-3,3'-digallate ameliorates learning and memory impairments in mice with premature brain aging induced by D-galactose","volume":"261","author":"Cao","year":"2023","journal-title":"Physiol. Behav."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383525006445?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383525006445?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T21:17:55Z","timestamp":1785273475000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383525006445"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":40,"alternative-id":["S0304383525006445"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2025.218072","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting the FBXO5-DOK6 axis to overcome temozolomide resistance in glioblastoma via proteasome-cytomechanics regulation","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2025.218072","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"218072"}}